Publications dans lesquelles il/elle collabore avec Miguel Ángel Martínez García (46)

2026

  1. Improving the multidimensional scoring systems in bronchiectasis: the role of cellular biomarkers

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, Vol. 30, Núm. 1, pp. 40-42

2025

  1. Effect of N-Acetylcysteine on Bronchiectasis in a Real-life Study. Data From the Spanish RIBRON Registry

    Archivos de Bronconeumologia, Vol. 61, Núm. 4, pp. 196-202

  2. Persistent Blood Eosinophilia and Eosinopenia: Relationship with Outcomes in Bronchiectasis

    Archivos de Bronconeumologia, Vol. 61, Núm. 8, pp. 484-489

  3. What is the optimal dose of N-acetylcysteine in adult patients with bronchiectasis?—data from the RIBRON registry

    Journal of Thoracic Disease, Vol. 17, Núm. 10, pp. 9003-9012

2024

  1. Reliability of blood eosinophil count in steady-state bronchiectasis

    Pulmonology

2023

  1. Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries

    Archivos de Bronconeumologia, Vol. 59, Núm. 10, pp. 688-690

  2. The U-Shaped Relationship Between Eosinophil Count and Bronchiectasis Severity: The Effect of Inhaled Corticosteroids

    Chest, Vol. 164, Núm. 3, pp. 606-613

  3. The role of precision medicine in bronchiectasis: emerging data and clinical implications

    Expert Review of Respiratory Medicine, Vol. 17, Núm. 4, pp. 279-293

  4. What Have We Learned About Bronchiectasis From RIBRON (Spanish Bronchiectasis Registry)?

    Archivos de Bronconeumologia

2022

  1. Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes

    Biomedicines, Vol. 10, Núm. 5

  2. Impact of Chronic Bronchial Infection by Staphylococcus aureus on Bronchiectasis

    Journal of Clinical Medicine, Vol. 11, Núm. 14

  3. Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by Pseudomonas aeruginosa: A Narrative Review of Current Evidence

    Infection and Drug Resistance, Vol. 15, pp. 7271-7292

  4. Peripheral Neutrophil-to-Lymphocyte Ratio in Bronchiectasis: A Marker of Disease Severity

    Biomolecules, Vol. 12, Núm. 10

  5. Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study

    Biomedicines, Vol. 10, Núm. 2

  6. The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives

    Microorganisms, Vol. 10, Núm. 4

2021

  1. C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON)

    Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 21-27

  2. Differences in nutritional status and inflammatory biomarkers between female and male patients with bronchiectasis: A large-cohort study

    Biomedicines, Vol. 9, Núm. 8

  3. Phenotypic clustering in non-cystic fibrosis bronchiectasis patients: The role of eosinophils in disease severity

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 16

  4. Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis

    Clinical Microbiology and Infection, Vol. 27, Núm. 3, pp. 428-434

  5. RIBRON: The spanish Online Bronchiectasis Registry. Characterization of the First 1912 Patients

    Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 28-35